Searchable abstracts of presentations at key conferences in endocrinology

ea0032p941 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Clinical presentation, treatment approach and outcomes of patients with prolactinomas in real-life clinical practice: a single center experience

Vicente Almudena , Satre Julia , Zaballos Florentino , Luque Ines , Luque Alessandra , Castro Enrique , Maqueda Esther , Marco Amparo , Lopez Jose

Introduction: Generously supported by IPSEN)-->Prolactin (PRL) -secreting adenomas are about 40% of all pituitary adenomas. Their clinical symptoms are mainly related to development of secondary hypogonadism and/or tumor mass effects. Dopamine agonists (DA) are first-line drugs for prolactinoma patients due to their effectiveness in normalizing PRL levels and shrinking tumour mass. Surgery is an option for DA failure or tumour mass e...

ea0041ep576 | Diabetes therapy | ECE2016

Trends and differences between sexes in control of diabetes and cardiovascular risk factors from 2004 to 2014

Vicente Almudena , Cortes Claudia , Olivar Monica , Martinez Ana , Sastre Julia , Marco Amparo , Luque Ines , Lopez Jose

Background: Poorer control of risk factors for cardiovascular disease (cvd) has been reported in diabetic women compared with men.Objective: To investigate whether control of diabetes and risk factors for cvd differ between sexes in a cohort of diabetic patients monitored at an outpatient endocrinology clinic from 2004 till 2014.Design: Observational, retrospective cohort study.Patients and methods: A cohort ...

ea0032p482 | Diabetes | ECE2013

Are there gender differences in liraglutide response in adults with type 2 diabetes?

Sastre Julia , Vicente Almudena , Maqueda Esther , Luque Ines , Castro Enrique , Marco Amparo , Pena Virginia , Lopez Jose

Background: Recent reports suggest that female sex could be an indicator of better response to liraglutide in patients included in clinical trials.Aim: To compare efficacy of liraglutide in women and men with type 2 diabetes mellitus (T2DM), in real clinical practice.Patients and methods: Our study included 116 patients with T2DM and obesity (BMI >30) attending outpatient clinic, which initiated with liraglutide (0.6 mg/daily f...

ea0016p85 | Bone and calcium | ECE2008

Clinical and hormonal variables to predict bone mineral density loss in anorexia nervosa patients

Gonzalez Amalia , Varsavsky Mariela , Fernandez Ines Luque , Leyva Socorro , Palma Moya Mercedes , Soto Marisa Fernandez

Objective: Anorexia nervosa (AN) is often associated with severe mineral bone loss and increased risk of fractures. The objective of this study was to assess the bone mineral density (BMD) in patients with AN and its relationship with different anthropometrics, clinical and hormonal parameters.Patients and methods: We evaluated 47 women with AN according to criteria of DSM-IV. The anthropometrics variables measured were: weight (kg) height (m), BMI (kg/m...

ea0035p1117 | Thyroid Cancer | ECE2014

Prediction of lymph node metastasis in papillary thyroid cancer by preoperative BRAF analysis, is it useful?

Luque Alessandra , Sastre Julia , Val Florentino del , Cortes Claudia , Luque Ines , Maqueda Esther , Vicente Almudena , Pena Virginia , Castro Enrique , Morlan Miguel Angel , Campos-Martin Yolanda , Lopez Jose

Introduction and objective: Prophylactic central lymph node dissection (CLND) in patients with suspected papillary thyroid cancer (PTC) without evident lymph node metastasis (LNM), remains debatable. We propose to evaluate whether BRAF V600E mutation presence, could help to identify patients at risk for LMN.Methods: Retrospective study of patients with diagnosis of PTC, who underwent total thyroidectomy during 2002 and 2013 (n: 256) in our hospi...